• National Pregnancy Registry for Psychiatric Medications
The National Pregnancy Registry for Atypical Antipsychotics is seeking pregnant women between the ages of 18 and 45.

This Massachusetts General Hospital Center for Women’s Mental Health research study will involve 3 brief phone interviews over an 8-month period.

To register, please call 1-866-961-2388.

The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics during pregnancy. You do not need to be taking an atypical antipsychotic to enroll in this study and there are only three phone interviews.

For more information, please call 1-866-961-2388.
Institution  –  MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator  – Lee Cohen, MD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Gina Savella
Phone  – 1-866-961-2388